Document:

<PAGE>

                                                                   Exhibit 10.25

June 30, 2004

Mark Pavao
2203 St. James Street
Philadelphia, Pennsylvania 19103

Dear Mark:

I would like to formally offer you the full-time position of Senior Vice
President of Marketing and Sales at NitroMed reporting to the President and
Chief Executive Officer and working in the field of NO-enhanced cardiovascular
medicines. The terms of this offer are as follows:

Responsibilities:   As Senior Vice President of Marketing and Sales, you will be
                    responsible for leading all the Company's marketing and
                    sales efforts, plus such other responsibilities as may be
                    assigned to you from time to time by the CEO.

Base Salary:        You will be paid $10,416.66 semi-monthly. Such salary may
                    be adjusted from time to time in accordance with normal
                    business practice at the sole discretion of the Company.

Sign-on Bonus:      You will receive a sign-on bonus in the amount of
                    $50,000 -- $25,000 paid on the first day of employment and
                    $25,000 paid on your one year anniversary date, assuming
                    that you are then employed by the Company.

Stock:              The Compensation Committee of the Company's Board of
                    Directors has agreed to grant you an option to purchase
                    125,000 shares of common stock of the Company upon your
                    commencement of employment. The closing price of the stock
                    on the date of grant will be the exercise price of these
                    options. These options will vest and become exercisable in
                    four equal annual installments beginning on the first
                    anniversary of your date of hire, subject to your continued
                    employment with the Company. This grant will be subject to
                    your execution and compliance with all terms of the
                    Company's standard incentive stock option agreement and to
                    all terms of the Company's Amended and Restated 2003 Stock
                    Incentive Plan, copy attached as Exhibit A.

Performance Bonus:  You may be entitled to receive a bonus under the NitroMed
                    bonus plan, which is discretionary and based on milestones
                    to be determined and mutually agreed upon by the CEO and
                    you. You will be entitled to receive a minimum guaranteed
                    first year bonus of 25% of your 2004 salary, payable in
                    part in December of 2004 prorated for the months remaining
                    between your date of hire and December 31, 2004, with the
                    balance to be paid in 2005. Such bonus shall be subject to
                    adjustment in 2005, depending on performance.

<PAGE>

Group Benefits:     You will be eligible to receive comprehensive group health,
                    disability, accident and life insurance benefits or such
                    comparable benefits and protections the Company is able to
                    reasonably obtain from another plan. You will be entitled to
                    participate in and enjoy the benefits of NitroMed's 401K
                    retirement plan as well as any other retirement and pension
                    plan or plans if and when instituted by the Company for the
                    benefit of its employees generally, provided that you are
                    eligible under (and subject to all provisions of) the plan
                    documents governing those programs.

Sick and Vacation:  You will be entitled to sick days consistent with the
                    Company's standard policy and 20 vacation days per year, to
                    be taken at such times as may be approved by the CEO.

Relocation:         Subject to your continued employment, the Company will
                    reimburse you up to a sum not to exceed $100,000.00 for
                    moving your household contents, including buy and sell side
                    costs such as commissions and fees. You will have 12 months
                    to exercise this relocation benefit. During the first year
                    of your employment, the Company will also reimburse
                    reasonable expenses incurred by you on no more than two
                    occasions to come to Massachusetts for the purpose of
                    evaluating the purchase of a home and up to $3,000 per month
                    for three months of temporary living expenses.

Cost of Housing     Subject to your continued employment, the Company will
                    reimburse your mortgage costs in an amount of up to $2,500
                    per year for three Adjustment: years All relocation and
                    housing costs reimbursed by the Company shall be subject to
                    withholding and other applicable employment taxes.

Agreements:         As a condition of employment, you will be required to
                    execute a non-competition agreement related to nitric oxide
                    enhanced medicines, in the form attached as Exhibit B.

Severance:          You will be entitled to salary continuation upon termination
                    without cause for a period of one year.

No Conflicts:       You represent that you are not bound by any employment
                    contract, restrictive covenant or other restriction
                    preventing you from entering into employment with or
                    carrying out your responsibilities for the Company, or that
                    is in any way inconsistent with the terms of this letter. To
                    the extent you are bound only by non-disclosure and
                    non-solicitation obligations, you agree that you will adhere
                    to those restrictions.

Employment at Will: Nothing in this letter agreement shall be construed as an
                    agreement, either express or implied, to employ you for any
                    stated term, and shall in no way alter the Company's policy
                    of employment at will, under which both you and the Company
                    remain free to end the employment relationship, for any
                    reason, at any time, with or without cause or notice.
                    Similarly, except as explicitly set forth herein, nothing in
                    this letter agreement shall be construed as an agreement,
                    either express or implied, to pay you any compensation or
                    grant you any benefit beyond the end of your employment with
                    the Company.

<PAGE>

If this letter correctly sets forth the terms under which you will be employed
by the Company, please sign the enclosed duplicate of this letter in the space
provided below and return it to Wanda Avril. The anticipated start date for this
position is on or before August 2, 2004. If we do not receive your acceptance,
this offer will be deemed revoked July 19, 2004.

On behalf of the NitroMed team and myself, let me say that we all very much look
forward to working alongside you. I know that together we will grow NitroMed and
BiDil.

Sincerely,

/s/ Michael D. Loberg
Michael D. Loberg
President and Chief Executive Officer

                                  The foregoing correctly sets forth the terms
                                  of my at-will employment with NitroMed, Inc.:

                                            /s/ Mark Pavao
                                            -----------------------------------
                                            Mark Pavao

                                            Dated:
                                                   ----------------------------<PAGE>

                                                                  Exhibit 10.26

           COMPENSATION OF NAMED EXECUTIVE OFFICERS OF NITROMED, INC.

         As of March 10, 2005, the following sets forth the  compensation of the
named  executive  officers (as defined in Item  402(a)(3) of Regulation  S-K) of
NitroMed, Inc.:

<TABLE>
<CAPTION>
                                                           CURRENT ANNUAL                            OTHER
EXECUTIVE OFFICER                                              SALARY            2004 BONUS      COMPENSATION(1)
<S>                                                        <C>                   <C>             <C>

Michael D. Loberg, Ph.D.
         President and Chief Executive Officer                $332,470            $116,365             $1,032

Manuel Worcel, M.D.
         Chief Medical Officer                                $268,830            $104,844             $3,048

L. Gordon Letts, Ph.D.
         Chief Scientific Officer and Senior Vice
         President, Research and Development                  $248,636             $62,159             $1,025

Lawrence E. Bloch, M.D., J.D.
         Chief Financial Officer and Chief Business
         Officer                                              $265,000            $22,083               $72

James G. Ham, III
         Vice President of Finance                            $180,000            $12,000               $224

Mark H. Pavao
         Senior Vice President of Sales and Marketing         $250,000            $31,250               $120
</TABLE>

(1) Amounts represent the payments of premiums on group term life insurance.

In addition, each of NitroMed, Inc.'s named executive officers is eligible to
participate in NitroMed's 2003 Amended and Restated Stock Incentive Plan and any
successor plan.<PAGE>

                                                                  Exhibit 10.27

        COMPENSATION PROGRAM FOR NON-EMPLOYEE DIRECTORS OF NITROMED, INC.

         As of March 10, 2005, the following sets forth the compensation program
for non-employee directors of NitroMed, Inc.:

         -  each director is eligible to receive (i) an option to purchase
            20,000 shares of Common Stock upon initial election, such shares
            to vest in four equal installments on the first, second, third and
            fourth anniversaries of the date of grant, and (ii) an option to
            purchase 15,000 shares of Common Stock annually thereafter upon
            re-election at the annual meeting of stockholders, such shares to
            vest in full on the first anniversary of the date of grant;

        -   each director is eligible to receive a retainer of $6,000 per
            calendar quarter;

        -   the chairman of the board of directors is eligible to receive an
            additional retainer of $5,000 per calendar year;

        -   audit committee members are eligible to receive $2,000 per audit
            committee meeting and the chair of the audit committee is eligible
            to receive an additional $2,000 annually; and

        -   compensating committee and nominating and corporate governance
            committee members are eligible to receive $1,000 per committee
            meeting and the chairs of such committees are each eligible to
            receive an additional $1,000 annually.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}]]